Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Biocides; animal or insect repellents or attractants
Reexamination Certificate
2011-07-19
2011-07-19
Alstrum Acevedo, James H (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Biocides; animal or insect repellents or attractants
C424S464000, C424S614000, C514S546000, C514S727000, C514S730000, C514S741000
Reexamination Certificate
active
07981439
ABSTRACT:
This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
REFERENCES:
patent: 3065143 (1962-11-01), Christenson et al.
patent: 3260646 (1966-07-01), Paulsen et al.
patent: 4070494 (1978-01-01), Hoffmeister et al.
patent: 4175119 (1979-11-01), Porter
patent: 4389393 (1983-06-01), Schor et al.
patent: 4457933 (1984-07-01), Gordon et al.
patent: 4459278 (1984-07-01), Porter
patent: 4599342 (1986-07-01), LaHann
patent: 4610870 (1986-09-01), Jain et al.
patent: 4666705 (1987-05-01), DeCrosta et al.
patent: 5059600 (1991-10-01), Gawin et al.
patent: 5114942 (1992-05-01), Gawin et al.
patent: 5284662 (1994-02-01), Koparkar et al.
patent: 5330766 (1994-07-01), Morella et al.
patent: 5741524 (1998-04-01), Staniforth et al.
patent: 5968551 (1999-10-01), Oshlack et al.
patent: 6153621 (2000-11-01), Hamann
patent: 6228863 (2001-05-01), Palermo et al.
patent: 6309668 (2001-10-01), Bastin et al.
patent: 6352721 (2002-03-01), Faour
patent: 6375957 (2002-04-01), Kaiko et al.
patent: 6491949 (2002-12-01), Faour et al.
patent: 6559159 (2003-05-01), Carroll et al.
patent: 6572885 (2003-06-01), Oshlack et al.
patent: 6589556 (2003-07-01), Cheruki et al.
patent: 6593367 (2003-07-01), Dewey et al.
patent: 6753009 (2004-06-01), Luber et al.
patent: 7141250 (2006-11-01), Oshlack et al.
patent: 7144587 (2006-12-01), Oshlack et al.
patent: 7157100 (2007-01-01), Doshi et al.
patent: 7157103 (2007-01-01), Sackler
patent: 7192966 (2007-03-01), Malyo-Alvarez
patent: 7201920 (2007-04-01), Kumar et al.
patent: 7332182 (2008-02-01), Sackler
patent: 7384653 (2008-06-01), Wright et al.
patent: 7476402 (2009-01-01), Kumar et al.
patent: 7510726 (2009-03-01), Kumar et al.
patent: 7524515 (2009-04-01), Roberts
patent: 2003/0004177 (2003-01-01), Kao et al.
patent: 2003/0064122 (2003-04-01), Goldberg et al.
patent: 2003/0068276 (2003-04-01), Hughes et al.
patent: 2003/0068371 (2003-04-01), Oshlack et al.
patent: 2003/0068375 (2003-04-01), Wright et al.
patent: 2003/0125347 (2003-07-01), Anderson et al.
patent: 2003/0170181 (2003-09-01), Midha
patent: 2004/0131552 (2004-07-01), Boehm
patent: 2004/0228802 (2004-11-01), Chang et al.
patent: 2005/0020613 (2005-01-01), Boehm et al.
patent: 2005/0106249 (2005-05-01), Hwang et al.
patent: 2006/0018837 (2006-01-01), Preston et al.
patent: 2006/0110327 (2006-05-01), Emigh et al.
patent: 2006/0177380 (2006-08-01), Emigh et al.
patent: 1293195 (2003-03-01), None
patent: 1428361 (1976-03-01), None
patent: 0016750 (2000-03-01), None
patent: 0016751 (2000-03-01), None
patent: 0033835 (2000-06-01), None
patent: 03026743 (2003-04-01), None
patent: 2004026256 (2004-04-01), None
patent: 2004026283 (2004-04-01), None
patent: 2004037259 (2004-05-01), None
patent: 2005053587 (2005-06-01), None
Board of Patent Appeals and Interferences Decision on Appeal mailed Aug. 16, 2010 in U.S. Appl. No. 11/136,636.
Office Action mailed Oct. 6, 2010 in U.S. Appl. No. 12/231,136 of Kumar et al.
Office Action mailed Sep. 11, 2007 in U.S. Appl. No. 11/136,636 of Emigh et al.
Office Action mailed Jun. 14, 2007 in U.S. Appl. No. 11/136,636 of Emigh et al.
Office Action mailed Jan. 23, 2007 in U.S. Appl. No. 11/136,636 of Emigh et al.
Office Action mailed Oct. 30, 2006 in U.S. Appl. No. 11/136,636 of Emigh et al.
Office Action mailed May 30, 2006 in U.S. Appl. No. 10/723,654.
Purdue Pharma, L.P. package inserts pp. 1-10 (OxyIR oral capsules) (printed 1996, 2003 and 2007)—see 5012 (U.S. Appl. No. 11/136,636).
Office Action mailed Sep. 15, 2010 in U.S. Appl. No. 11/724,502.
Office Action mailed Apr. 27, 2010 in U.S. Appl. No. 11/287,012.
Wells et al., “Effect of Anionic Surfactants on the Release of Chlorpheniramine Maleate From an Inert, Heterogeneous Matrix.” Drug Development . . . 18(2), 1992, pp 175-186.
Rao et al., “Effect of Sodium Lauryl Sulfate on the Release of Rifampicin from Guar Gum Matrix.” Indian Journal of Pharmaceuticals Science, Sep.-Oct. 2000.
Matschiner et al., “Characterization of Ion Pair Formation Between Erythromycin and Lipophilic Counter Ions.” Pharmazie 50(1995): 462-464.
Supplementary European Search Report from EP Pat. App. No. 04812083.6, dated Aug. 20, 2008.
International Search Report and Written Opinion of the International Search Authority from International Application No. PCT/US2005/042808, dated Aug. 5, 2008.
Dixon David
Kumar Vijai
Tewari Divya
Wadgaonkar Dilip B.
Acevedo James H Alstrum
Acura Pharmaceuticals, Inc.
Morgan & Lewis & Bockius, LLP
LandOfFree
Methods and compositions for deterring abuse of drugs... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for deterring abuse of drugs..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for deterring abuse of drugs... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2623230